Cite
HARVARD Citation
Girnius, S. et al. (n.d.). A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation. British journal of haematology. pp. 36-43. [Online].